2023
September 21, 2023
Inclusivity at the forefront of our clinical trials
September 21, 2023
Sanofi CHC North America earns B Corp Certification
September 21, 2023
Pilot take-back programs for insulin pens launched in 2 European countries
June 1, 2023
Sanofi partnering with the Ghana Ministry of Health to improve affordable access to diabetes care
June 1, 2023
Sanofi capping its insulin to a $35 out-of-pocket costs in the U.S.
June 1, 2023
Net Zero towards 2045
March 9, 2023
Sanofi Global Health Unit impact fund first investment in Swipe RX
February 6, 2023
Transform the treatment of sleeping sickness
February 6, 2023
